CD44 and cancer: Furthermore, CD44‐HA binding has a roll‐on effect that enhances the treatment resistance properties of cancer cells via increased multidrug resistance protein 1 (MDR1) expression and epithelial‐to‐mesenchymal transition (EMT) pathway upregulation [26].